Kelly L Wyres
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (10)
Background Klebsiella pneumoniae is the leading cause of sepsis among neonates in low- and middle-income countries (LMICs) in Africa and Asia, contributing substantially to the overall burden of antimicrobial resistant (AMR) infections and mortality among neonates globally. Pathogen sequencing has been used to investigate case clusters and confirm nosocomial transmission in a small number of neonatal units. Here we utilise pathogen sequence data to estimate the fraction of K. pneumoniae neonatal sepsis attributable to nosocomial transmission in African and South Asian countries. Methods and Findings We estimated the proportion of invasive K. pneumoniae disease involved in nosocomial transmission clusters in a given neonatal unit, using single-linkage clustering based on pairwise temporal and genetic distances estimated from bacterial whole-genome sequences aggregated from 10 contributing studies. Analysing 1,523 K. pneumoniae isolates from 27 units in 13 countries in Africa and South Asia between 2013 and 2023, we inferred 156 nosocomial transmission clusters, ranging from 2 to 188 neonates each (83 of the clusters comprised ≥3 cases). Overall, we estimated that 1,035 neonatal infections (68.0%) were part of nosocomial transmission clusters. Excluding the first infection in each cluster as a potential index case, we estimate at least 879 (57.7%) infections were acquired via nosocomial transmission. Sensitivity analyses showed that results were robust to the choice of genetic distance estimation methods and thresholds used to define clusters, and cluster estimates were stable over temporal distance thresholds ranging from 2 to 8 weeks. Isolates were mostly extended-spectrum beta-lactamase (ESBL) producers (90.9%) and included 172 multi-locus sequence types (STs). Fourteen STs, including several globally recognised multidrug-resistant lineages, were associated with transmission clusters at multiple units and these were collectively responsible for two-thirds of all infections. Carriage of carbapenemase genes (adjusted odds ratio, aOR = 2.08 [95% confidence interval, CI: 1.04–4.14], p=0.02) and ESBL genes (aOR = 2.48 [95% CI: 1.26–4.90] p=0.006) were significantly positively associated with transmission. Conclusions Nosocomial transmission contributes to a substantial proportion of K. pneumoniae sepsis in neonatal care units in Africa and South Asia. Reducing transmission within these settings through improved infection prevention and control and other measures could substantially reduce the neonatal sepsis burden. A high burden of transmission clusters is associated with the same drug-resistant lineages that are recognised as high-risk clones associated with hospital outbreaks in high-income countries, indicating global connectivity of the AMR pathogen population. Author Summary Why Was This Study Done? Klebsiella pneumoniae is the leading cause of sepsis among neonates in low- and middle-income countries (LMICs) in Africa and Asia, and the infections are difficult to treat due to rising rates of antimicrobial resistance. Invasive bacterial diseases are typically transmitted to neonates from their mothers before, during or soon after birth (vertical transmission) or from the hospital environment and healthcare workers (horizontal transmission). The fraction of K. pneumoniae neonatal sepsis cases attributable to horizontal transmission is unknown, but this information is important to understand the role of infection prevention and control (IPC) measures in lowering disease burden. What Did the Researchers Do and Find? We developed a simple method to detect transmission clusters from genetic and temporal distance data and found the method to be robust to the choice of genetic and temporal distance thresholds. We applied this method to detect transmission clusters among 1,523 K. pneumoniae neonatal sepsis cases from 10 studies and 27 hospitals across Africa and South Asia. We estimate over half of sepsis cases (68.0%) were part of
Year:
2025
BACKGROUND Ciprofloxacin resistant Klebsiella pneumoniae is common or emerging in many geographies, and knowledge of local resistance rates is important for empirical therapy. Whilst there are known K. pneumoniae ciprofloxacin resistance determinants, there is a lack of systematic data on the effect of determinants, alone and in combination, and there are no publicly accessible tools for predicting resistance from whole genome sequence data. METHODS The KlebNET-GSP AMR Genotype-Phenotype Group aggregated a matched genotype-phenotype dataset of n=12,167 K. pneumoniae species complex ( Kp SC) isolates from 27 countries between 2001-2021. We developed a rules-based classifier to predict ciprofloxacin resistance by categorizing the number of quinolone resistance determining regions mutations in gyrA and parC , the number of plasmid-mediated quinolone resistance genes, and the presence/absence of aac(6ʹ)-Ib-cr (which can acetylate ciprofloxacin). Predictive performance was assessed using the discovery dataset, for which we re-phenotyped discrepant isolates; and validated using externally contributed datasets (n=7,030 Kp SC isolates). RESULTS The rules-based classifier predicted R vs S/I with categorical agreement, sensitivity, and specificity >96%, and major/very major error rates <4%. Performance was similar across diverse Kp SC sources (human, animal, other), species, and intra-species lineages. External validation of the classifier yielded overall 93.12% categorical agreement [95% confidence interval (CI), 92.50-93.74%], 8.65% major errors [95% CI, 7.34-9.97%], and 6.20% very major errors [95% CI, 5.51-6.90%]. We implemented the classifier in Kleborate, a command-line tool that is integrated into the Pathogenwatch web platform. Using this to assess the global distribution of ciprofloxacin resistance determinants in Kp SC genomes available in Pathogenwatch (n=31,319, from 109 countries between years 2000-2023), we observed a significant positive association between national quinolone consumption rates and predicted ciprofloxacin resistance (R 2 =0.20, p=0.004). CONCLUSIONS Ciprofloxacin resistance phenotypes can be reasonably predicted from genotypes, which is sufficient for informing surveillance. However, unexplained resistance remains and accuracy is insufficient for clinical applications. We demonstrate the value of aggregating genotype-phenotype data to explore resistance mechanisms and develop predictors, but highlight complexities in combining phenotype data from different assays and standards.
Year:
2025
Introduction Klebsiella pneumoniae is an opportunistic pathogen which causes a wide spectrum of infections within healthcare settings and the community. Four K. pneumoniae sub-lineages defined with cgMLST/LINcodes are known to cause distinct infections of the nasal and/or upper respiratory passages: SL91 and SL10031 (also referred to as subspecies ozaenae ), SL10032 (subspecies rhinoscleromatis ) and SL82. These sub-lineages have also demonstrated reduced carbon source utilisation, which in other species has been linked with high loads of insertion sequences (IS). Methods We performed comparative genomics, analysed IS and constructed genome-scale metabolic models for available public sequences from these four sub-lineages and compared them to other sub-lineages from the wider K. pneumoniae population. Results The four focal sub-lineages displayed significantly higher IS loads (median range 88 to 120 per genome) compared to other K. pneumoniae sub-lineages (median range 12 to 73). Notably, each K. pneumoniae sub-lineage had unique IS profiles, consistent with distinct evolutionary trajectories of IS acquisition and expansion. Across sub-lineages, higher IS loads were inversely associated with the number of metabolic model genes per genome (R 2 = 0.16, p <0.001), as well as predicted aerobic substrate utilisation for phosphorus sources (R 2 = 0.39, p<0.001) as per a second-degree polynomial regression model (n = 1,664 genomes). Additionally, the four IS-dense sub-lineages displayed a combination of convergent sub-lineage-specific substrate utilisation losses including parallel loss of 3-Phospho-D-glycerate, D-Glycerate-2-phosphate, Phosphoenolpyruvate utilisation as carbon/phosphorus sources. Finally, inspection of IS insertion sites demonstrated frequent and non-destructive insertion next to transcriptional, carbohydrate and amino acid metabolism genes. Conclusions IS loads were significantly and inversely associated with metabolic substrate usage within K. pneumoniae , whereby sub-lineages that had higher numbers of IS also had reduced metabolic capacity. We hypothesise that an insertional tolerance model explains these findings, whereby IS can only insert into “metabolically-tolerable” sites for the individual cell and any impacts on metabolism are not detrimental for survival.
Year:
2025
Background: Klebsiella pneumoniae causes ~20% of sepsis in neonates, with ~40% crude mortality. A vaccine administered to pregnant women, protecting against 70% of K. pneumoniae infections, could avert ~400,000 cases and ~80,000 deaths annually, mostly in Africa and South Asia. Vaccine formulations targeting the capsular polysaccharide (K) or lipopolysaccharide (O) antigens are in development. Global K. pneumoniae populations display extensive K and O diversity, necessitating a polyvalent vaccine targeted to the serotypes associated with neonatal disease in relevant geographical regions. We investigated the prevalence of K and O types associated with neonatal sepsis in Africa and South Asia to inform maternal vaccine design. Methods and Findings: We analysed n=1930 K. pneumoniae neonate blood isolates from 13 surveillance studies across 35 sites in 13 countries. We used pathogen sequencing to predict K and O serotypes and adjust for local transmission clusters, and Bayesian hierarchical meta-analysis to estimate K and O prevalence overall and per region, treating site as a random effect. Eighty-seven K loci were identified. KL2, KL102, KL25, KL15 and KL62 accounted for 49% of isolates. We estimate that 20 K loci, combining the eight most prevalent per region, could cover 72.9% of all infections [95% credible interval, 69.4&—76.5%] and ≥70% in each of Eastern, Western and Southern Africa and South Asia. Preliminary findings from three sites suggested sufficient temporal stability of K loci to maintain 20-valent K vaccine coverage over 5-10 years, but more longitudinal data are needed to support this prediction. O types were far less diverse (n=14 types). We estimate the top-5 (O1⍺β,2⍺, O1⍺β,2β, O2⍺, O2β and O4) would cover 86.2% [82.6—89.9%] of total infections (76—92% per region), while the top-10 would cover 99% of infections in all four regions. Conclusions: Neonatal sepsis is associated with diverse K and O types, with substantial geographic and temporal variation even after adjusting for localised transmission clusters. Despite this, a single 20-valent K vaccine could theoretically cover ≥70% of infections in all target regions. Locally-targeted vaccines could achieve higher coverage with lower valency, but are less feasible. In principle, very high coverage could be achieved with lower valency O-based vaccines, however protective efficacy of antibodies targeting the O antigen remains uncertain. Further research is needed on cross-reactivity, antigen exposure and stability of antigens over time, to better inform vaccine development.
Year:
2025
Surface polysaccharides are common antigens in priority pathogens and therefore attractive targets for novel control strategies such as vaccines, monoclonal antibody and phage therapies. Distinct serotypes correspond to diverse polysaccharide structures that are encoded by distinct biosynthesis gene clusters, e.g. the Klebsiella pneumoniae species complex (KpSC) K- and O-loci encode the synthesis machinery for the capsule (K) and outer-lipopolysaccharides (O), respectively. We previously presented Kaptive and Kaptive 2, programs to identify K and O-loci directly from KpSC genome assemblies (later adapted for Acinetobacter baumannii ), enabling sero-epidemiological analyses to guide vaccine and phage therapy development. However, for some KpSC genome collections, Kaptive (v≤2) was unable to type a high proportion of K-loci. Here we identify the cause of this issue as assembly fragmentation, and present a new version of Kaptive (v3) to circumvent this problem, reduce processing times and simplify output interpretation. We compared the performance of Kaptive v2 and Kaptive v3 for typing genome assemblies generated from subsampled Illumina read sets (decrements of 10x depth), for which a corresponding high quality completed genome was also available to determine the ‘true’ loci (n=549 KpSC, n=198 A. baumannii ). Both versions of Kaptive showed high rates of agreement to the matched true locus among ‘typeable’ locus calls (≥96% for ≥20x read depth), but Kaptive v3 was more sensitive, particularly for low depth assemblies (at 1 order of magnitude faster than Kaptive v2 making it easy to analyse thousands of assemblies on a desktop computer, facilitating broadly accessible in silico serotyping that is both accurate and sensitive. The Kaptive v3 source code is freely available on GitHub ( https://github.com/klebgenomics/Kaptive ), and has been implemented in Kaptive Web ( https://kaptive-web.erc.monash.edu ).
Year:
2025
Background: Bacteria are typically isolated on rich media to maximise isolation success, removing them from their native evolutionary context. This eliminates selection pressures, enabling otherwise deleterious genomic events to accumulate. Here we present a cautionary tale of these 'quiet mutations' which can persist unnoticed in bacterial culture lines. Methods: We used a combination of microbiological culture (standard and minimal media conditions), whole genome sequencing and metabolic modelling to investigate putative Klebsiella pneumoniae L-histidine auxotrophs. Additionally, we used genome-scale metabolic modelling to predict auxotrophies among completed public genomes (n=2,637). Results: Two sub-populations were identified within a K. pneumoniae frozen stock, differing in their ability to grow in the absence of L-histidine. These sub-populations were the same 'strain', separated by eight single nucleotide variants and an insertion sequence-mediated deletion of the L-histidine biosynthetic operon. The His- sub-population remained undetected for >10 years despite its in inclusion in independent laboratory experiments. Genome-scale metabolic models predicted 0.8% public genomes contained greater than or equal to 1 auxotrophy, with purine/pyrimidine biosynthesis and amino acid metabolism most frequently implicated. Discussion: We provide a definitive example of the role of standard rich media culture conditions in obscuring biologically relevant mutations i.e. nutrient auxotrophies, and estimate the prevalence of such auxotrophies using public genome collections. While the prevalence is low, it is not insignificant given the thousands of K. pneumoniae that are isolated for global surveillance and research studies each year. Our data serve as a pertinent reminder that rich-media culturing can cause unnoticed wild type domestication.
Year:
2024
The Klebsiella pneumoniae species complex inhabits a wide variety of hosts and environments, and is a major cause of antimicrobial resistant infections. Genomics has revealed the population comprises multiple species/subspecies and hundreds of distinct co-circulating sub-lineages that are associated with distinct gene complements. A substantial fraction of the pan-genome is predicted to be involved in metabolic functions and hence these data are consistent with metabolic differentiation as a driver of population structure. However, this has so far remained unsubstantiated because in the past it was not possible to explore metabolic variation at scale. Here we used a combination of comparative genomics and high-throughput genome-scale metabolic modelling to systematically explore metabolic diversity across the K. pneumoniae species complex (n=7,835 genomes). We simulated growth outcomes for each isolate using carbon, nitrogen, phosphorus and sulfur sources under aerobic and anaerobic conditions (n=1,278 conditions per isolate). We showed that the distributions of metabolic genes and growth capabilities are structured in the population, and confirmed that sub-lineages exhibit unique metabolic profiles. In vitro co-culture experiments demonstrated reciprocal commensalistic cross-feeding between sub-lineages, effectively extending the range of conditions supporting individual growth. We propose that these substrate specialisations promote the existence and persistence of co-circulating sub-lineages by reducing nutrient competition and facilitating commensal interactions via negative frequency-dependent selection. Our findings have implications for understanding the eco-evolutionary dynamics of K. pneumoniae and for the design of novel strategies to prevent opportunistic infections caused by this World Health Organization priority antimicrobial resistant pathogen.
Year:
2024
Background Klebsiella pneumoniae is an opportunistic pathogen and a leading cause of healthcare-associated infections in hospitals, which are frequently antimicrobial resistant (AMR). Exacerbating the public health threat posed by K. pneumoniae , some strains also harbor additional hypervirulence determinants typically acquired via mobile genetic elements such as the well-characterised large virulence plasmid KpVP-1. The rmpADC locus is considered a key virulence feature of K. pneumoniae and is associated with upregulated capsule expression and the hypermucoid phenotype, which can enhance virulence by contributing to serum resistance. Typically such strains have been susceptible to all antimicrobials besides ampicillin, however the recent emergence of AMR hypermucoid strains is concerning. Methods Here, we investigate the genetic diversity, evolution, mobilisation and prevalence of rmpADC , in a dataset of 14000 genomes from isolates of the Klebsiella pneumoniae species complex, and describe the RmST virulence typing scheme for tracking rmpADC variants for the purposes of genomic surveillance. Additionally, we examine the functionality of representatives for variants of rmpADC introduced into a mutant strain lacking its native rmpADC locus. Results The rmpADC locus was detected in 7% of the dataset, mostly from genomes of K. pneumoniae and a very small number of K. variicola and K. quasipneumoniae . Sequence variants of rmpADC grouped into five distinct lineages ( rmp1, rmp2, rmp2A, rmp3 and rmp4 ) that corresponded to unique mobile elements, and were differentially distributed across different populations (i.e. clonal groups) of K. pneumoniae . All variants were demonstrated to produce enhanced capsule production and hypermucoviscosity. Conclusion These results provide an overview of the diversity and evolution of a prominent K. pneumoniae virulence factor and support the idea that screening for rmpADC in K. pneumoniae isolates and genomes is valuable to monitor the emergence and spread of hypermucoid K. pneumoniae , including AMR strains.
Year:
2024
Unified strain taxonomies are needed for the epidemiological surveillance of bacterial pathogens and international communication in microbiological research. Core genome multilocus sequence typing (cgMLST) holds great promise for standardized high-resolution strain genotyping. However, this approach faces challenges including classification instability and disconnection of new nomenclature from widely adopted classical MLST identifiers. This essay discusses the cgMLST-based Life Identification Number (LIN) method, recently proposed as a stable multilevel strain taxonomy system applicable to most bacterial pathogens. We describe how LIN codes are implemented and used in practice for precise strain definitions and epidemiological tracking. Glossary Multilocus sequence typing (MLST) A genotyping method applied mostly to microbial strains to study population structure and epidemiology, based on comparing the nucleotide sequences of a small number (typically seven) of housekeeping protein-coding genes. In MLST, allele numbers are assigned to each sequence variant (allele) of a given gene. The MLST genotype of a bacterial strain is defined by the combination of the allele numbers observed at the genes that are included in the genotyping scheme. A sequence type (ST) is assigned to each unique combination of alleles, called an MLST profile. MLST was invented in 1998 and became a de-facto standard taxonomy of bacterial strains, albeit at low resolution. Core genome MLST An extension of MLST that analyzes sequence variation across hundreds to thousands of conserved (core) genes, shared by all strains of a species, providing higher resolution typing for genomic epidemiology and evolutionary studies. cgMLST schemes typically comprise 2000 to 4000 genes, depending on the genome size and genetic variation (in terms of presence/absence of genes) within bacterial species. A core genome sequence type (cgST) can be assigned to unique cgMLST profiles, i.e., a unique combination of cgMLST allelic numbers. Whole Genome Sequencing (WGS) A method that determines the complete DNA sequence of an organism’s genome in a single process, providing comprehensive information for comparative genetic analyses based on cgMLST or other analytic methods. Single Nucleotide Polymorphisms (SNPs) Variations at a single base position in the DNA sequence among individuals isolates, strains or species, used as genetic markers for studying for example, evolutionary relationships or strain identity. Average nucleotide identity (ANI) A measure of genomic similarity between two organisms, calculated as the average percentage of identical nucleotides in orthologous genomic regions; commonly used to assess species-level relatedness in prokaryotes. Taxonomy Here, we apply the word taxonomy to bacterial strains as a system of classifying, naming and identifying strains based on shared genetic characteristics as defined by e.g., cgMLST.
Year:
2024
Year:
2023
Collaborators (55)
Paul Turner
University of Oxford
Ørjan Samuelsen
Professor
UiT The Arctic University of Norway
Helena Seth-Smith
Co-Leader of Microbial Genomics Devision
University of Zurich
Nicole Stoesser
Associate Professor
University of Oxford
Amy Mathers
Professor
University of Virginia
Alexis Criscuolo
Université Paris-Saclay
Ahmed Magdi Moustafa
Assistant Professor of Pediatrics
University of Pennsylvania Perelman School of Medicine
Michael Bachman
Assistant Professor
University of Michigan
francesco pomilio
Head of Unit
Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche
Sandra Reuter
Research Group Leader
University Medical Center Freiburg
Benjamin P. Howden
-
Koji Yahara
Group Leader
National Institute of Infectious Diseases
Arnfinn Sundsfjord
-
Alexandra Chiaverini
Ricercatore Sanitario (Cat. DS6) Veterinario
Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche
Sam Lipworth
University of Oxford
Andrew McArthur
Professor
McMaster University
M. Estée Török
University of Cambridge
Charlene Rodrigues
Assistant Professor in Microbial Genomics
London School of Hygiene & Tropical Medicine
Adrian Egli
Professor
University of Zurich
Kathryn Holt
Professor (Research)
MONASH UNIVERSITY
Leah Wendy Roberts
Queensland University of Technology
Daniela Maria Cirillo
Head of Unit
Ospedale San Raffaele
Tommaso Giani
Associate Professor
University of Florence
Teresa M. Coque
-
Erkison Odih
Københavns Universitet
Marianne Sunde
Norwegian Veterinary Institute
Gian Maria Rossolini
Professor
University of Florence
M. C. J. Maiden
University of Oxford
Jukka Corander
University of Oslo
Motoyuki Sugai
-
Melanie Hennart
Institut Pasteur
Susana Campino
London School of Hygiene & Tropical Medicine
Iren H. Löhr
Stavanger University Hospital
D. Sassera
University of Pavia
Stephen Baker
University of Cambridge School of Clinical Medicine
Andrea Spitaleri
Researcher
Human Technopole
James Berkley
Senior Research Group Leader
University of Oxford
Norelle Sherry
Deputy Director
University of Melbourne
Eva Heinz
Senior Lecturer
University Of Strathclyde
Melese Hailu Legese
Lecturer
Uppsala Universitet Uppsala biomedicinska centrum
Marisa Haenni
-
Sylvain Brisse
Université Paris Cité
Edward Feil
Professor at Department of Life Sciences
University of Bath
Patrick N. A. Harris
University of Queensland
Taane Clark
Professor of Genomics and Global Health
London School of Hygiene & Tropical Medicine
Claire Gorrie
University of Melbourne
Joao Perdigao
Professor do ensino Básico e Secundário
Ministério da Educação
Shizuo Kayama
National Institute of Infectious Diseases
Davidson Hamer
Professor of Global Health and Medicine
Boston University
Keith Jolley
Bioinformatician
University of Oxford
Nicholas Thomson
Head of Programme
Wellcome Sanger Institute
Harry Thorpe
University of Oslo
Muhammad Imran Nisar
Associate Professor and Vice Chair Research
Aga Khan University
Nicholas Feasey
Professor
Liverpool School of Tropical Medicine
David Aanensen
Professor
University of Oxford
Make your next move.
Prepare your application
Review drafts before you send them.